Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardl...

di Weng, Wen-Kai, Czerwinski, Debra, Levy, Ronald
Pubblicazione 2007

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells

di Irish, Jonathan M., Czerwinski, Debra K., Nolan, Garry P., Levy, Ronald
Pubblicazione 2006

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors

di Brody, Joshua D., Goldstein, Matthew J., Czerwinski, Debra K., Levy, Ronald
Pubblicazione 2009

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

di Ai, Weiyun Z., Tibshirani, Robert, Taidi, Behnaz, Czerwinski, Debra, Levy, Ronald
Pubblicazione 2009

Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma

di Sagiv-Barfi, Idit, Kohrt, Holbrook E., Burckhardt, Laura, Czerwinski, Debra K., Levy, Ronald
Pubblicato in Blood (2015)

Follicular lymphoma B cells induce the conversion of conventional CD4(+) T cells to T regulatory cells

di Ai, Weiyun Z., Hou, Jing-Zhou, Zeiser, Robert, Czerwinski, Debra, Negrin, Robert S., Levy, Ronald
Pubblicazione 2009

Eradication of spontaneous malignancy by local immunotherapy

di Sagiv-Barfi, Idit, Czerwinski, Debra K., Levy, Shoshana, Alam, Israt S., Mayer, Aaron T., Gambhir, Sanjiv S., Levy, Ronald
Pubblicato in Sci Transl Med (2018)

Generation of CD8(+) T cell–mediated immunity against idiotype-negative lymphoma escapees

di Varghese, Bindu, Widman, Adam, Do, James, Taidi, Behnaz, Czerwinski, Debra K., Timmerman, John, Levy, Shoshana, Levy, Ronald
Pubblicazione 2009

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

di Sagiv-Barfi, Idit, Kohrt, Holbrook E. K., Czerwinski, Debra K., Ng, Patrick P., Chang, Betty Y., Levy, Ronald
Pubblicato in Proc Natl Acad Sci U S A (2015)

A CpG-loaded tumor cell vaccine induces antitumor CD4(+) T cells that are effective in adoptive therapy for large and established tumors

di Goldstein, Matthew J., Varghese, Bindu, Brody, Joshua D., Rajapaksa, Ranjani, Kohrt, Holbrook, Czerwinski, Debra K., Levy, Shoshana, Levy, Ronald
Pubblicazione 2011

T-cell immunopeptidomes reveal cell subtype surface markers derived from intracellular proteins

di Olsson, Niclas, Schultz, Liora M, Zhang, Lichao, Khodadoust, Michael S., Narayan, Rupa, Czerwinski, Debra K., Levy, Ronald, Elias, Joshua E.
Pubblicato in Proteomics (2018)

CD81 is a novel immunotherapeutic target for B cell lymphoma

di Vences-Catalán, Felipe, Kuo, Chiung-Chi, Rajapaksa, Ranjani, Duault, Caroline, Andor, Noemi, Czerwinski, Debra K., Levy, Ronald, Levy, Shoshana
Pubblicato in J Exp Med (2019)

Downregulation of Protein 4.1R, a Mature Centriole Protein, Disrupts Centrosomes, Alters Cell Cycle Progression, and Perturbs Mitotic Spindles and Anaphase

di Krauss, Sharon Wald, Spence, Jeffrey R., Bahmanyar, Shirin, Barth, Angela I. M., Go, Minjoung M., Czerwinski, Debra, Meyer, Adam J.
Pubblicazione 2008

Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation

di Kohrt, Holbrook E., Müller, Antonia, Baker, Jeanette, Goldstein, Matthew J., Newell, Evan, Dutt, Suparna, Czerwinski, Debra, Lowsky, Robert, Strober, Samuel
Pubblicazione 2011

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

di Timmerman, John M., Vose, Julie M., Czerwinski, Debra K., Weng, Wen-Kai, Ingolia, Diane, Mayo, Martha, Denney, Dan W., Levy, Ronald
Pubblicazione 2009

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression

di Irish, Jonathan M., Myklebust, June H., Alizadeh, Ash A., Houot, Roch, Sharman, Jeff P., Czerwinski, Debra K., Nolan, Garry P., Levy, Ronald
Pubblicazione 2010

Imaging activated T cells predicts response to cancer vaccines

di Alam, Israt S., Mayer, Aaron T., Sagiv-Barfi, Idit, Wang, Kezheng, Vermesh, Ophir, Czerwinski, Debra K., Johnson, Emily M., James, Michelle L., Levy, Ronald, Gambhir, Sanjiv S.
Pubblicato in J Clin Invest (2018)

Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin

di Narayan, Rupa, Olsson, Niclas, Wagar, Lisa E., Medeiros, Bruno C., Meyer, Everett, Czerwinski, Debra, Khodadoust, Michael S., Zhang, Lichao, Schultz, Liora, Davis, Mark M., Elias, Joshua E., Levy, Ron
Pubblicato in PLoS One (2019)

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

di Mueller, Antonia MS, Hebb, Jonathan, Sagiv-Barfi, Idit, Marabelle, Aurelien, Houot, Roch, Rajapaksa, Amanda, Czerwinski, Debra K, Chang, Serena, Chester, Cariad, Sadaram, Mohith, Waller, Erin, Levy, Ronald, Kohrt, Holbrook
Pubblicato in J Immunother Cancer (2014)

CANCER VACCINES AND T CELL THERAPY

di Rezvani, Katayoun, Brody, Joshua D., Kohrt, Holbrook E., Logan, Aaron C., Advani, Ranjana, Czerwinski, Debra Katherine, Weng, Wen-Kai, Negrin, Robert S., Carlton, Victoria, Faham, Malek, Levy, Ronald, Barrett, John
Pubblicato in Biol Blood Marrow Transplant (2012)